EP 3697394 A1 20200826 - TRANSDERMAL DELIVERY SYSTEM CONTAINING A DOPAMINE AGONIST
Title (en)
TRANSDERMAL DELIVERY SYSTEM CONTAINING A DOPAMINE AGONIST
Title (de)
TRANSDERMALES DARREICHUNGSSYSTEM ENTHALTEND EINEN DOPAMINAGONISTEN
Title (fr)
SYSTÈME GALÉNIQUE TRANSDERMIQUE CONTENANT UN AGONISTE DE DOPAMINE
Publication
Application
Priority
- DE 102017124627 A 20171020
- EP 2018078731 W 20181019
Abstract (en)
[origin: WO2019077116A1] The invention relates to a transdermal delivery system (TDS) comprising at least one dopamine agonist, said at least one dopamine agonist being in a matrix containing at least one polymer from the class of polybutylenes. The invention further relates to a process for manufacturing the TDS of the invention as well as to the use of the TDS of the invention.
IPC 8 full level
A61K 9/70 (2006.01); A61K 31/381 (2006.01)
CPC (source: EP US)
A61K 9/7084 (2013.01 - EP US); A61K 9/7092 (2013.01 - US); A61K 31/381 (2013.01 - EP US); A61K 47/10 (2013.01 - US); A61K 47/14 (2013.01 - US); A61K 47/32 (2013.01 - US); B65D 81/266 (2013.01 - US)
Citation (search report)
See references of WO 2019077116A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2019077116 A1 20190425; DE 102017124627 A1 20190425; EP 3697394 A1 20200826; US 2021145761 A1 20210520
DOCDB simple family (application)
EP 2018078731 W 20181019; DE 102017124627 A 20171020; EP 18792907 A 20181019; US 201816757290 A 20181019